These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 31943204)
1. Prekallikrein - an emerging therapeutic target for Klebsiella pneumoniae infection? Lam Z; Condliffe AM J Pathol; 2020 Apr; 250(4):359-361. PubMed ID: 31943204 [TBL] [Abstract][Full Text] [Related]
2. Prekallikrein inhibits innate immune signaling in the lung and impairs host defense during pneumosepsis in mice. Ding C; Scicluna BP; Stroo I; Yang J; Roelofs JJ; de Boer OJ; de Vos AF; Nürnberg P; Revenko AS; Crosby J; Van't Veer C; van der Poll T J Pathol; 2020 Jan; 250(1):95-106. PubMed ID: 31595971 [TBL] [Abstract][Full Text] [Related]
3. Zhou YF; Tao MT; Huo W; Liao XP; Sun J; Liu YH Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264844 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection. Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 improves local immunity during Gram-negative pneumonia by a combined effect on neutrophils and inflammatory monocytes. Ramirez-Moral I; Blok DC; Bernink JH; Garcia-Laorden MI; Florquin S; Boon L; Van't Veer C; Mack M; Saluzzo S; Knapp S; Spits H; de Vos AF; van der Poll T J Pathol; 2021 Apr; 253(4):374-383. PubMed ID: 33305354 [TBL] [Abstract][Full Text] [Related]
6. Limited role of kininogen in the host response during gram-negative pneumonia-derived sepsis. Ding C; van 't Veer C; Roelofs JJTH; Shukla M; McCrae KR; Revenko AS; Crosby J; van der Poll T Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L397-L405. PubMed ID: 29122754 [TBL] [Abstract][Full Text] [Related]
7. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae. Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Lepak AJ; Andes DR Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072 [TBL] [Abstract][Full Text] [Related]
9. Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Enterobacter cloacae in a patient receiving meropenem therapy. Martins ER; Estofolete CF; Zequini AB; Cerdeira L; de Oliveira Garcia D; Bueno MFC; Francisco GR; de Andrade LN; da Costa Darini AL; Tolentino FM; Casella T; Lincopan N; Nogueira MCL Diagn Microbiol Infect Dis; 2017 Jul; 88(3):287-289. PubMed ID: 28442305 [TBL] [Abstract][Full Text] [Related]
10. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice. de Paula TP; Santos PC; Arifa RDDN; Vieira AT; Baltazar LM; Ávila TV; Fagundes CT; Garcia ZM; Lima RL; Teixeira MM; Souza DG Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463546 [TBL] [Abstract][Full Text] [Related]
11. Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Paczosa MK; Mecsas J Microbiol Mol Biol Rev; 2016 Sep; 80(3):629-61. PubMed ID: 27307579 [TBL] [Abstract][Full Text] [Related]
12. Using Klebsiella pneumoniae to Model Acute Lung Inflammation in Mice. McDaniel DK; Allen IC Methods Mol Biol; 2019; 1960():169-180. PubMed ID: 30798531 [TBL] [Abstract][Full Text] [Related]
13. Experimental model of Klebsiella infection in mice for studies on mechanisms of local immunity of the respiratory tract. Libich J; Franĕk J; Hásková V Folia Microbiol (Praha); 1983; 28(5):424-9. PubMed ID: 6357970 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Action of Antimicrobial Lung Proteins against Fraile-Ágreda V; Cañadas O; Weaver TE; Casals C Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681806 [TBL] [Abstract][Full Text] [Related]
15. The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation. Chung PY FEMS Microbiol Lett; 2016 Oct; 363(20):. PubMed ID: 27664057 [TBL] [Abstract][Full Text] [Related]
16. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742 [TBL] [Abstract][Full Text] [Related]
18. Colistin resistance in Klebsiella pneumoniae. Ah YM; Kim AJ; Lee JY Int J Antimicrob Agents; 2014 Jul; 44(1):8-15. PubMed ID: 24794735 [TBL] [Abstract][Full Text] [Related]